Search

Nigel D Priestley

from Alberton, MT
Age ~58
Get Report
Also known as:
Nigel Priestley, Nigel Priestly
Phone and address:
950 Fork Petty Creek Rd, Alberton, MT 59820
Connected to:
Christopher E Priestly, 49Dustin T Priestly, 41Emma L Priestley, 42Everlin V Priestley, 65Gavin E Priestley, 28Nathaniel F Priestley, 88Patricia G Priestner, 78Rachael A Priestley, 45Maria PrietlAj Prieto, 51

Nigel Priestley Phones & Addresses

  • 950 Fork Petty Creek Rd, Alberton, MT 59820
  • Missoula, MT
  • Westerville, OH
  • Columbus, OH
  • Seattle, WA
  • 950 W Fork Petty Creek Rd, Alberton, MT 59820 (406) 864-0001

Work

Company: Promiliad biopharma incorporated Address: 950 W Fork Petty Creek Rd, Alberton, MT 59820 Phones: (406) 864-0022 Position: Chief executive officer Industries: Pharmaceutical Preparations

Education

Degree: Bachelor's degree or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Nigel Priestley
Chief Executive Officer
Promiliad Biopharma Incorporated
Pharmaceutical Preparations
950 W Fork Petty Creek Rd, Alberton, MT 59820
Nigel Priestley
Chief Executive Officer
Promiliad Biopharma Inc
Chemicals Dealers · Government Contractors · Pharmaceutical Products Wholesale & Manufacturers
950 W Frk Petty Crk Rd, Alberton, MT 59820
(406) 864-0022
Nigel Priestley
Chief Executive Officer
Promiliad Biopharma Incorporated
Pharmaceutical Preparations
950 W Fork Petty Creek Rd, Alberton, MT 59820

Publications

Us Patents

Synthesis Of Methyl Nonactate Derivatives

View page
US Patent:
20100056779, Mar 4, 2010
Filed:
Sep 11, 2007
Appl. No.:
12/441140
Inventors:
Stephen C. Bergmeier - Athens OH, US
Nigel D. Priestley - Alberton MT, US
Assignee:
OHIO UNIVERSITY - Athens OH
International Classification:
C07D 405/14
C07D 405/06
C07D 413/14
US Classification:
544121, 548255, 544366, 546210, 544357
Abstract:
Methyl nonactate is converted into a variety of different triazoloamide antibacterial agents by a reaction scheme involving (1) inversion of the secondary alcohol of the methyl nonactate to produce the corresponding azidoester, (2) converting the azido ester to the corresponding azidoamide, and (3) converting the azido group of the azidoamide to a triazole to produce the corresponding triazoloamide.

16-Methyl-Oxacyclohexadecan-2-One And 16-Methyl-Azacyclohexadecan-2-One Derivatives As Antimicrobial Agents

View page
US Patent:
20200017460, Jan 16, 2020
Filed:
Mar 20, 2018
Appl. No.:
16/495312
Inventors:
- Missoula MT, US
Donald STIERLE - Missoula MT, US
Nigel PRIESTLEY - Alberton MT, US
Assignee:
THE UNIVERSITY OF MONTANA - Missoula MT
International Classification:
C07D 313/00
A61P 31/04
C07D 405/04
C07D 491/044
Abstract:
16-membered macrolide compounds inhibit growth of various microbial species and have utility in the treatment of systemic or topical microbial infections, including methicillin-resistant strains (Formula I).
Control profile
Nigel D Priestley from Alberton, MT, age ~58 Get Report